Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.54 |
| ▸ | HTR7 | P34969 | 11/20 | 0.53 |
| ▸ | HTR2A | P28223 | 8/20 | 0.53 |
| ▸ | HTR6 | P50406 | 7/20 | 0.53 |
| ▸ | DRD2 | P14416 | 6/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 2/20 | 0.45 |
| ▸ | HTR2C | P28335 | 2/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18507066 | 0.88 | HTR7 (0.53) | CCR1HTR7HTR2AHTR6L3MBTL1 | |
| SCHEMBL17194300 | 0.88 | HTR7 (0.61) | CCR1HTR7HTR2AHTR6L3MBTL1 | |
| SCHEMBL18501758 | 0.87 | L3MBTL1 (0.54) | CCR1HTR7HTR2AHTR6DRD2 | |
| SCHEMBL18502069 | 0.86 | MBTD1 (0.55) | HTR7L3MBTL1MBTD1HTR1AKDM4E | |
| SCHEMBL18507070 | 0.85 | HTR7 (0.58) | CCR1HTR7HTR2AHTR6DRD2 | |
| SCHEMBL18507122 | 0.85 | HTR7 (0.50) | CCR1HTR7HTR2AHTR6L3MBTL1 | |
| SCHEMBL18502084 | 0.85 | KMT2A (0.60) | CCR1HTR7L3MBTL1MBTD1HRH3 | |
| SCHEMBL17194302 | 0.85 | L3MBTL1 (0.70) | CCR1HTR7HTR2AL3MBTL1MBTD1 | |
| SCHEMBL18502057 | 0.83 | MBTD1 (0.52) | HTR7HTR2AL3MBTL1MBTD1HTR1A | |
| SCHEMBL18506938 | 0.83 | L3MBTL1 (0.52) | CCR1HTR7L3MBTL1MBTD1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9809602-B2 | Compounds for treating viral infections | INSTITUT PASTEUR KOREA (KR) | 2017-11-07 | — | — | US | disclosed |
| US-20170044181-A1 | COMPOUNDS FOR TREATING VIRAL INFECTIONS | INSTITUT PASTEUR KOREA (KR) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044181-A1 | COMPOUNDS FOR TREATING VIRAL INFECTIONS | HAVCR2, MAVS, EIF2AK2 | CCR1 425/4885HTR7 4489/4885HTR2A 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.